- Lobbying
- Lobbying by Tethys Bioscience
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Jennifer Leib | Policy Fellow, NIH/NHGRI Office of the Director Policy Fellow, NHI/NHGRI Office of the Director |
Kathryn Schubert | Legislative Director, Rep. Wayne T. Gilchrest |
Nicholas G. Cavarocchi | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Termination
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Disease Control & Prevention (CDC),
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Disease Control & Prevention (CDC),
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Disease Control & Prevention (CDC),
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Disease Control & Prevention (CDC),
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Disease Control & Prevention (CDC),
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Registration
Issue(s) they said they’d lobby about: Issues relating to health care policy and the prevention of diabetes
Regulation of laboratory developed tests..
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Registration
Issue(s) they said they’d lobby about: Issues relating to health care policy and the prevention of diabetes
Regulation of laboratory developed tests..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate